Madzharova E, Sabino F, Kalogeropoulos K, Francavilla C, Auf dem Keller U
Protein Sci. 2024; 33(8):e5128.
PMID: 39074261
PMC: 11285871.
DOI: 10.1002/pro.5128.
Benlarbi M, Laroche G, Fink C, Fu K, Mulloy R, Phan A
iScience. 2022; 25(11):105316.
PMID: 36254158
PMC: 9549715.
DOI: 10.1016/j.isci.2022.105316.
Norville K, Skrombolas D, Ferry S, Kearns N, Frelinger J
J Interferon Cytokine Res. 2022; 42(7):316-328.
PMID: 35834651
PMC: 9347422.
DOI: 10.1089/jir.2022.0043.
Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K
Cancers (Basel). 2022; 14(7).
PMID: 35406619
PMC: 8998077.
DOI: 10.3390/cancers14071847.
Baldini L, Lenci E, Bianchini F, Trabocchi A
Molecules. 2022; 27(4).
PMID: 35209039
PMC: 8879803.
DOI: 10.3390/molecules27041249.
Antimicrobial and enzyme-responsive multi-peptide surfaces for bone-anchored devices.
Fischer N, Chen X, Astleford-Hopper K, He J, Mullikin A, Mansky K
Mater Sci Eng C Mater Biol Appl. 2021; 125:112108.
PMID: 33965114
PMC: 8117048.
DOI: 10.1016/j.msec.2021.112108.
Increased pro-MMP9 plasma levels are associated with neovascular age-related macular degeneration and with the risk allele of rs142450006 near .
Lauwen S, Lefeber D, Fauser S, Hoyng C, den Hollander A
Mol Vis. 2021; 27:142-150.
PMID: 33907369
PMC: 8056465.
Quantitative profiling of protease specificity.
Ratnikov B, Cieplak P, Remacle A, Nguyen E, Smith J
PLoS Comput Biol. 2021; 17(2):e1008101.
PMID: 33617527
PMC: 7932537.
DOI: 10.1371/journal.pcbi.1008101.
A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines.
Pourseif M, Parvizpour S, Jafari B, Dehghani J, Naghili B, Omidi Y
Bioimpacts. 2021; 11(1):65-84.
PMID: 33469510
PMC: 7803919.
DOI: 10.34172/bi.2021.11.
Single Domain Antibodies Targeting Receptor Binding Pockets of NadA Restrain Adhesion of to Human Brain Microvascular Endothelial Cells.
Kulkarni A, Mochnacova E, Majerova P, curlik J, Bhide K, Mertinkova P
Front Mol Biosci. 2021; 7:573281.
PMID: 33425985
PMC: 7785856.
DOI: 10.3389/fmolb.2020.573281.
Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library.
Yano H, Nishimiya D, Kawaguchi Y, Tamura M, Hashimoto R
PLoS One. 2020; 15(12):e0244656.
PMID: 33373399
PMC: 7771667.
DOI: 10.1371/journal.pone.0244656.
Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin.
Kostov K, Blazhev A
Medicina (Kaunas). 2020; 56(5).
PMID: 32403389
PMC: 7279148.
DOI: 10.3390/medicina56050231.
Role of Matrix Metalloproteinases in Angiogenesis and Cancer.
Quintero-Fabian S, Arreola R, Becerril-Villanueva E, Torres-Romero J, Arana-Argaez V, Lara-Riegos J
Front Oncol. 2020; 9:1370.
PMID: 31921634
PMC: 6915110.
DOI: 10.3389/fonc.2019.01370.
Silencing of nuclear factor kappa b 1 gene expression inhibits colony formation, cell migration and invasion via the downregulation of interleukin 1 beta and matrix metallopeptidase 9 in renal cell carcinoma.
S Teixeira L, Peron J, Bellini M
Mol Biol Rep. 2019; 47(2):1143-1151.
PMID: 31820316
DOI: 10.1007/s11033-019-05212-9.
Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9.
Skrombolas D, Sullivan M, Frelinger J
J Interferon Cytokine Res. 2019; 39(4):233-245.
PMID: 30848689
PMC: 6479256.
DOI: 10.1089/jir.2018.0129.
Customizing Morphology, Size, and Response Kinetics of Matrix Metalloproteinase-Responsive Nanostructures by Systematic Peptide Design.
Son J, Kalafatovic D, Kumar M, Yoo B, Cornejo M, Contel M
ACS Nano. 2019; 13(2):1555-1562.
PMID: 30689363
PMC: 6475088.
DOI: 10.1021/acsnano.8b07401.
Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.
Huang H
Sensors (Basel). 2018; 18(10).
PMID: 30262739
PMC: 6211011.
DOI: 10.3390/s18103249.
Dissecting MMP P' and P' subsite sequence preferences, utilizing a positional scanning, combinatorial triple-helical peptide library.
Tokmina-Roszyk M, Fields G
J Biol Chem. 2018; 293(43):16661-16676.
PMID: 30185620
PMC: 6204916.
DOI: 10.1074/jbc.RA118.003266.
Design of an allosterically modulated doxycycline and doxorubicin drug-binding protein.
Schmidt K, Gardill B, Kern A, Kirchweger P, Borsch M, Muller Y
Proc Natl Acad Sci U S A. 2018; 115(22):5744-5749.
PMID: 29760101
PMC: 5984491.
DOI: 10.1073/pnas.1716666115.
High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13.
Kretz C, Tomberg K, Van Esbroeck A, Yee A, Ginsburg D
Sci Rep. 2018; 8(1):2788.
PMID: 29434246
PMC: 5809430.
DOI: 10.1038/s41598-018-21021-9.